<i>PCLO</i> Is Associated with Tumor Mutational Burden and Immunity in Patients with Oral Squamous Cell Carcinoma
To determine predictive biomarkers for prognosis by analyzing the association between tumor mutational burden (TMB) and mutant genes in patients with oral squamous cell carcinoma (OSCC) and to validate <i>PCLO</i> as an OSCC predictive biomarker, OSCC genetic mutation data were downloade...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/6/426 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | To determine predictive biomarkers for prognosis by analyzing the association between tumor mutational burden (TMB) and mutant genes in patients with oral squamous cell carcinoma (OSCC) and to validate <i>PCLO</i> as an OSCC predictive biomarker, OSCC genetic mutation data were downloaded from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) database. Immune cell infiltration analysis and visualization were performed using R software. The relationships between overall survival (OS) and mutant genes or clinicopathological factors were investigated by Kaplan–Meier analysis and Cox regression analysis, respectively. Gene set enrichment analysis (GSEA) was used to explore the associations between mutant genes and functional pathways. Immunohistochemistry was performed to verify the presence of the piccolo protein in OSCC tissues. Finally, 17 mutated genes shared between TCGA and the ICGC database were detected. The TMB in the <i>PCLO</i>-mutated group was found to be significantly greater than that in the <i>PCLO</i> wild-type group, and <i>PCLO</i> mutation was associated with poor OS. Cox regression analysis revealed that <i>PCLO</i> is a significant prognostic factor for OSCC. GSEA and immune cell infiltration analysis revealed that <i>PCLO</i> is associated with the immune system, which suggests that <i>PCLO</i> mutation might affect the immune response. <i>PCLO</i> expression was considerably higher in OSCC tissues with <i>PCLO</i> mutations than in corresponding normal epithelium tissues and OSCC tissues without <i>PCLO</i> mutations (<i>p</i> < 0.05). <i>PCLO</i> mutation could serve as a promising predictive biomarker for prognosis in patients with OSCC. |
|---|---|
| ISSN: | 1467-3037 1467-3045 |